Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2018 Aug 1;46(4):948–956. doi: 10.1007/s00259-018-4105-1

Figure 1.

Figure 1.

BLI binding assays of ME07 towards recombinant human wtEGFR (a) and mutant EGFRvIII proteins (b). In these assays, the biosensors pre-coated with streptavidin interacted with biotinylated wtEGFR or EGFRvIII protein, followed by exposure to different concentrations of ME07 (0.97~1000 nM) for association and then to PBS for dissociation.